Earnings · China A-shares
Zhejiang Xinguang Pharmaceutical Co. Ltd. Class A (300519) earnings
Zhejiang Xinguang Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-22: net profit +41.39% year on year, +39.46% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +6.81% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-22
- Period end
- 2026-09-30
- Net profit YoY
- +41.39%
- Excl. one-offs YoY
- +39.46%
- Net profit QoQ
- +82.76%
- Result
- Good
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +8.83% | — |
| 3 days | +6.81% | — |
| 7 days | +3.98% | — |
| 14 days | +5.72% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 5 of 7 reports (average +1.52%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-23 | ¥64.10M | +41.39% | +39.46% | +2.60% | 0.40 | 7.56% | +6.81% | — | — |
| 2026 interim report | 2026-08-25 | ¥39.71M | +24.46% | +23.00% | +1.17% | 0.25 | 4.68% | +6.04% | +4.69% | +10.71% |
| 2026 Q1 report | 2026-04-21 | ¥26.37M | +7.44% | +8.01% | -5.13% | 0.16 | 3.10% | +1.17% | -13.96% | -17.41% |
| 2025 annual report | 2026-04-21 | ¥54.21M | +7.58% | +9.25% | -0.86% | 0.34 | 6.53% | +1.17% | -13.96% | -17.41% |
| 2025 Q3 report | 2025-10-28 | ¥45.34M | +19.99% | +25.86% | -4.90% | 0.28 | 5.45% | -3.37% | +6.38% | +9.76% |
| 2025 interim report | 2025-08-26 | ¥31.91M | +25.09% | +30.41% | -3.60% | 0.20 | 3.80% | -6.20% | -9.71% | -11.38% |
| 2025 Q1 report | 2025-04-28 | ¥24.54M | +7.50% | +9.49% | -7.26% | 0.15 | 2.91% | +1.71% | +12.79% | +9.54% |
| 2024 annual report | 2025-04-21 | ¥50.39M | -21.70% | -24.50% | -1.01% | 0.31 | 6.06% | +4.45% | +16.13% | +13.18% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.